Examining Associations Between Smartphone Use and Clinical Severity in Frontotemporal Dementia: Proof-of-Concept Study
Open accessPublished version of a preprint
The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
Background: Frontotemporal lobar degeneration (FTLD) is a leading cause of dementia in individuals aged <65 years. Several challenges to conducting in-person evaluations in FTLD illustrate an urgent need to develop remote, accessible, and low-burden assessment techniques. Studies of unobtrusive monitoring of at-home computer use in older adults with mild cognitive impairment show that declining function is reflected in reduced computer use; however, associations with smartphone use are unknown. Objective: This study aims to characterize daily trajectories in smartphone battery use, a proxy for smartphone use, and examine relationships with clinical indicators of severity in FTLD. Methods: Participants were 231 adults (mean age 52.5, SD 14.9 years; n=94, 40.7% men; n=223, 96.5% non-Hispanic White) enrolled in the Advancing Research and Treatment of Frontotemporal Lobar Degeneration (ARTFL study) and Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS study) Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) Mobile App study, including 49 (21.2%) with mild neurobehavioral changes and no functional impairment (ie, prodromal FTLD), 43 (18.6%) with neurobehavioral changes and functional impairment (ie, symptomatic FTLD), and 139 (60.2%) clinically normal adults, of whom 55 (39.6%) harbored heterozygous pathogenic or likely pathogenic variants in an autosomal dominant FTLD gene. Participants completed the Clinical Dementia Rating plus National Alzheimer’s Coordinating Center Frontotemporal Lobar Degeneration Behavior and Language Domains (CDR+NACC FTLD) scale, a neuropsychological battery; the Neuropsychiatric Inventory; and brain magnetic resonance imaging. The ALLFTD Mobile App was installed on participants’ smartphones for remote, passive, and continuous monitoring of smartphone use. Battery percentage was collected every 15 minutes over an average of 28 (SD 4.2; range 14-30) days. To determine whether temporal patterns of battery percentage varied as a function of disease severity, linear mixed effects models examined linear, quadratic, and cubic effects of the time of day and their interactions with each measure of disease severity on battery percentage. Models covaried for age, sex, smartphone type, and estimated smartphone age. Results: The CDR+NACC FTLD global score interacted with time on battery percentage such that participants with prodromal or symptomatic FTLD demonstrated less change in battery percentage throughout the day (a proxy for less smartphone use) than clinically normal participants (P<.001 in both cases). Additional models showed that worse performance in all cognitive domains assessed (ie, executive functioning, memory, language, and visuospatial skills), more neuropsychiatric symptoms, and smaller brain volumes also associated with less battery use throughout the day (P<.001 in all cases). Conclusions: These findings support a proof of concept that passively collected data about smartphone use behaviors associate with clinical impairment in FTLD. This work underscores the need for future studies to develop and validate passive digital markers sensitive to longitudinal clinical decline across neurodegenerative diseases, with potential to enhance real-world monitoring of neurobehavioral change.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For example, in the ALLFTD cohort, participants with prodromal or symptomatic frontotemporal lobar degeneration (FTLD) demonstrated less change in battery percentage (a proxy for less phone usage) than those without symptoms, and less battery use was associated with worse cognitive test results, more neuropsychiatric symptoms, and smaller brain volumes. 64”
From Developing digital health technologies for frontotemporal degeneration (2025) · cites this paper as [64]
The cited source says what the claim attributes to it.
In the citing paper
“Preliminary studies of the ALLFTD mApp suggest that passively collected data about smartphone use behaviors are associated with clinical functioning in FTD.”
From Developing digital health technologies for frontotemporal degeneration (2025) · cites this paper as [64]
The cited source says what the claim attributes to it.
In the citing paper
“For example, in the ALLFTD cohort, participants with prodromal or symptomatic frontotemporal lobar degeneration (FTLD) demonstrated less change in battery percentage (a proxy for less phone usage) than those without symptoms, and less battery use was associated with worse cognitive test results, more neuropsychiatric symptoms, and smaller brain volumes. 64”
From Developing digital health technologies for frontotemporal degeneration (2025) · cites this paper as [64]
The cited source says what the claim attributes to it.
In the citing paper
“For example, in the ALLFTD cohort, participants with prodromal or symptomatic frontotemporal lobar degeneration (FTLD) demonstrated less change in battery percentage (a proxy for less phone usage) than those without symptoms, and less battery use was associated with worse cognitive test results, more neuropsychiatric symptoms, and smaller brain volumes. 64”
From Developing digital health technologies for frontotemporal degeneration (2025) · cites this paper as [64]
The cited source says what the claim attributes to it.
In the citing paper
“For example, in the ALLFTD cohort, participants with prodromal or symptomatic frontotemporal lobar degeneration (FTLD) demonstrated less change in battery percentage (a proxy for less phone usage) than those without symptoms, and less battery use was associated with worse cognitive test results, more neuropsychiatric symptoms, and smaller brain volumes. 64”
From Developing digital health technologies for frontotemporal degeneration (2025) · cites this paper as [64]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fitting Linear Mixed-Effects Models Using lme4
Bates, D., Mächler, M., Bolker, B., & Walker, S. (2015) · Journal of Statistical Software · doi:10.18637/jss.v067.i01 · Cited by 86,835
Lecanemab in early Alzheimer's disease
van Dyck, C. H., Swanson, C. J., Aisen, P., Bateman, R. J., Chen, C., Gee, M., Kanekiyo, M., Li, D., Reyderman, L., Cohen, S., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2212948 · Cited by 5,678 · cited 1×
“As we enter the era of disease-modifying treatments for neurodegenerative diseases, early detection is critical to identify those eligible for clinical trial participation and early treatment to slow or stop disease progression [8-10].”
BackgroundSensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221 · cited 1×
“…symptoms at the prodromal stage (ie, no functional impairment) or fully symptomatic (ie, with functional impairment) level of severity that are consistent with an FTLD-related clinical phenotype per conference consensus with neurologists and neuropsychologists following published criteria [32-35].”
BackgroundSelf-citationClassification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141
Self-citationAppelhof, B., Bakker, C., Van Duinen-van den Ijssel, J. C. L., Zwijsen, S. A., Smalbrugge, M., Verhey, F. R. J., de Vugt, M. E., Zuidema, S. U., & Koopmans, R. T. C. M. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000477087 · Cited by 2,760
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
Höglinger, G. U., Respondek, G., Stamelou, M., Kurz, C., Josephs, K. A., Lang, A. E., Mollenhauer, B., Müller, U., Nilsson, C., Whitwell, J. L., et al. (2017) · Movement Disorders · doi:10.1002/mds.26987 · Cited by 2,359
Self-citationQualitative Assessment of Verbal Fluency Performance in Frontotemporal Dementia
van den Berg, E., Jiskoot, L. C., Grosveld, M. J. H., van Swieten, J. C., & Papma, J. M. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000477538 · Cited by 2,046
Validation of the NPI-Q, a Brief Clinical Form of the Neuropsychiatric Inventory
Kaufer, D., Cummings, J. L., Ketchel, P., Smith, V. M., MacMillan, A., Shelley, T., López, O. L., & DeKosky, S. T. (2000) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.12.2.233 · Cited by 1,973 · cited 1×
“Informants also completed the Neuropsychiatric Inventory [47] to assess the presence and severity of neuropsychiatric symptoms in participants.”
Criteria for the diagnosis of corticobasal degeneration
Armstrong, M. J., Litvan, I., Lang, A. E., Bak, T. H., Bhatia, K. P., Borroni, B., Boxer, A. L., Dickson, D. W., Grossman, M., Hallett, M., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31827f0fd1 · Cited by 1,904 · cited 1×
“…symptoms at the prodromal stage (ie, no functional impairment) or fully symptomatic (ie, with functional impairment) level of severity that are consistent with an FTLD-related clinical phenotype per conference consensus with neurologists and neuropsychologists following published criteria [32-35].”
BackgroundSelf-citationMorris, J. C. (1997) · International Psychogeriatrics · doi:10.1017/s1041610297004870 · Cited by 1,641 · cited 1×
“…the level of cognitive and everyday functioning impairment using the CDR+NACC FTLD scale [38], which is a validated, modified version of the CDR [39] that has higher sensitivity to functional impairment in FTLD. CDR+NACC FTLD global scores [40] were used to categorize participants into disease…”
MethodCalifornia Verbal Learning Test
Delis, D. C., Freeland, J., Kramer, J. H., & Kaplan, E. (2016) · PsycTESTS Dataset · doi:10.1037/t48844-000 · Cited by 1,319
Self-citationA meta-analysis of depression severity and cognitive function
McDermott, L. M., & Ebmeier, K. P. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.04.022 · Cited by 956 · cited 1×
“…only a snapshot of neurobehavioral functioning, which does not account for the dynamic nature of human behavior that fluctuates diurnally and is influenced by other dynamic factors (eg, sleep, fatigue, mood, and medications), limiting sensitivity for detecting early subtle declines [11,12].”
BackgroundWeintraub, S., Besser, L., Dodge, H. H., Teylan, M., Ferris, S., Goldstein, F. C., Giordani, B., Kramer, J., Loewenstein, D., Marson, D., et al. (2018) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000223 · Cited by 671 · cited 1×
“…published Uniform Data Set (Version 3) Executive Function composite score was used as our measure of executive functioning, comprising Trail Making Test A and B, phonemic fluency (generating words beginning with F and L), number span backwards, and category fluency (animals and vegetables) [41,42].”
MethodSelf-citationGOLLAN, T. H., WEISSBERGER, G. H., RUNNQVIST, E., MONTOYA, R. I., & CERA, C. M. (2012) · Bilingualism: Language and Cognition · doi:10.1017/s1366728911000332 · Cited by 527 · cited 1×
“Language functioning was assessed via the Multilingual Naming Test [46].”
MethodKramer, J. H., Jurik, J., Sha, S. J., Rankin, K. P., Rosen, H. J., Johnson, J. K., & Miller, B. L. (2003) · Cognitive and Behavioral Neurology · doi:10.1097/00146965-200312000-00002 · Cited by 502 · cited 1×
“Sample-based z scores were calculated for indices of memory, including immediate and delayed free recall on the California Verbal Learning Test-3 Brief Form [43], as well as Benson Complex Figure Delayed Recall [44,45].”
MethodSelf-citationAlzheimer’s Disease – Why We Need Early Diagnosis
Rasmussen, J., & Langerman, H. (2019) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s228939 · Cited by 501
Global Prevalence of Young-Onset Dementia: A Systematic Review and Meta-analysis
Hendriks, S., Peetoom, K., Bakker, C., van der Flier, W. M., Papma, J. M., Koopmans, R., Verhey, F. R. J., de Vugt, M., Köhler, S., Young-Onset Dementia Epidemiology Study Group, et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.2161 · Cited by 409
Economic burden of Alzheimer disease and managed care considerations
(2020) · The American Journal of Managed Care · doi:10.37765/ajmc.2020.88482 · Cited by 398
Clinicopathological correlations in behavioural variant frontotemporal dementia
Perry, D. C., Brown, J. A., Possin, K. L., Datta, S., Trujillo, A., Radke, A., Karydas, A., Kornak, J., Sias, A. C., Rabinovici, G. D., et al. (2017) · Brain · doi:10.1093/brain/awx254 · Cited by 309 · cited 1×
“FTLD encompasses a group of neuropathologically distinct diseases that result in an overlapping set of dementia syndromes with heterogeneous symptoms, including those defined by primary behavior, language, or sensorimotor changes [3,4].”
BackgroundSelf-citationPiau, A., Wild, K., Mattek, N., & Kaye, J. (2019) · Journal of Medical Internet Research · doi:10.2196/12785 · Cited by 252
Possin, K. L., Laluz, V. R., Alcantar, O. Z., Miller, B. L., & Kramer, J. H. (2011) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2010.10.026 · Cited by 249 · cited 2×
“Sample-based z scores were calculated for indices of memory, including immediate and delayed free recall on the California Verbal Learning Test-3 Brief Form [43], as well as Benson Complex Figure Delayed Recall [44,45].”
MethodSelf-citationEstimating the Number of Persons with Frontotemporal Lobar Degeneration in the US Population
Knopman, D. S., & Roberts, R. O. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9538-y · Cited by 236 · cited 1×
“Frontotemporal lobar degeneration (FTLD) is a common cause of dementia in individuals aged 65 years [1,2].”
BackgroundDigital Phenotyping for Monitoring Mental Disorders: Systematic Review
Bufano, P., Laurino, M., Said, S., Tognetti, A., & Menicucci, D. (2023) · Journal of Medical Internet Research · doi:10.2196/46778 · Cited by 168 · cited 1×
“Participants were only included in this secondary analysis of the ALLFTD Mobile App study if they had at least 14 continuous days of passive smartphone monitoring data, consistent with prior digital phenotyping studies attempting to capture typical daily behavior [31].”
ResultMiyagawa, T., Brushaber, D., Syrjanen, J., Kremers, W., Fields, J., Forsberg, L. K., Heuer, H. W., Knopman, D., Kornak, J., Boxer, A., et al. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12033 · Cited by 165
Self-citationCircadian rhythms in cognitive performance: implications for neuropsychological assessment
Valdéz, P., Ramírez, C., & García, A. (2012) · ChronoPhysiology and Therapy · doi:10.2147/cpt.s32586 · Cited by 152 · cited 1×
“…only a snapshot of neurobehavioral functioning, which does not account for the dynamic nature of human behavior that fluctuates diurnally and is influenced by other dynamic factors (eg, sleep, fatigue, mood, and medications), limiting sensitivity for detecting early subtle declines [11,12].”
BackgroundUnobtrusive measurement of daily computer use to detect mild cognitive impairment
Kaye, J., Mattek, N., Dodge, H. H., Campbell, I., Hayes, T., Austin, D., Hatt, W., Wild, K., Jimison, H., & Pavel, M. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.01.011 · Cited by 145 · cited 4×
“These findings are consistent with previous studies showing that older adults with cognitive impairment have greater declines in everyday technology use compared to cognitively unimpaired older adults [18,51,52].”
BackgroundMethodResultInfluentialTemporal order of clinical and biomarker changes in familial frontotemporal dementia
Staffaroni, A. M., Quintana, M., Wendelberger, B., Heuer, H. W., Russell, L. L., Cobigo, Y., Wolf, A., Goh, S.-Y. M., Petrucelli, L., Gendron, T. F., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01942-9 · Cited by 140 · cited 2×
“As we enter the era of disease-modifying treatments for neurodegenerative diseases, early detection is critical to identify those eligible for clinical trial participation and early treatment to slow or stop disease progression [8-10].”
BackgroundSelf-citationMalinowsky, C., Almkvist, O., Kottorp, A., & Nygård, L. (2010) · Disability and Rehabilitation: Assistive Technology · doi:10.3109/17483107.2010.496098 · Cited by 123 · cited 1×
“Other studies have shown that older adults with cognitive impairment report more difficulties using technology, representing a potential barrier to technology use [53,54].”
BackgroundDetection of Motor Impairment in Parkinson's Disease Via Mobile Touchscreen Typing
Arroyo-Gallego, T., Ledesma-Carbayo, M. J., Sanchez-Ferro, A., Butterworth, I., Mendoza, C. S., Matarazzo, M., Montero, P., Lopez-Blanco, R., Puertas-Martin, V., Trincado, R., et al. (2017) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2017.2664802 · Cited by 110
Lipsmeier, F., Taylor, K. I., Postuma, R. B., Volkova-Volkmar, E., Kilchenmann, T., Mollenhauer, B., Bamdadian, A., Popp, W. L., Cheng, W.-Y., Zhang, Y.-P., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-15874-4 · Cited by 109
Language and behavior domains enhance the value of the clinical dementia rating scale
Knopman, D. S., Weintraub, S., & Pankratz, V. S. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.12.006 · Cited by 105 · cited 1×
“…and participant interviews were conducted to characterize the level of cognitive and everyday functioning impairment using the CDR+NACC FTLD scale [38], which is a validated, modified version of the CDR [39] that has higher sensitivity to functional impairment in FTLD. CDR+NACC FTLD global scores…”
MethodRahmati, A., Tossell, C. C., Shepard, C. W., Kortum, P. T., & Zhong, L. (2012) · International Conference on Human-Computer Interaction with Mobile Devices and Services (MobileHCI) · doi:10.1145/2371574.2371577 · Cited by 105
Global incidence of young‐onset dementia: A systematic review and meta‐analysis
Hendriks, S., Peetoom, K. K. B., Bakker, C., Koopmans, R. T. C. M., van der Flier, W. M., Papma, J. M., Verhey, F. R. J., Young‐Onset Dementia Epidemiology Study Group, de Vugt, M. E., & Köhler, S. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12695 · Cited by 99
Computer mouse movement patterns: A potential marker of mild cognitive impairment
Seelye, A. M., Hagler, S., Mattek, N., Howieson, D. B., Wild, K. V., Dodge, H. H., & Kaye, J. A. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.09.006 · Cited by 98
Iakovakis, D., Hadjidimitriou, S., Charisis, V., Bostantzopoulou, S., Katsarou, Z., & Hadjileontiadis, L. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-25999-0 · Cited by 92
Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium
Miyagawa, T., Brushaber, D., Syrjanen, J., Kremers, W., Fields, J., Forsberg, L. K., Heuer, H. W., Knopman, D., Kornak, J., Boxer, A., et al. (2020) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.05.013 · Cited by 92
Self-citationGPS driving: a digital biomarker for preclinical Alzheimer disease
Bayat, S., Babulal, G. M., Schindler, S. E., Fagan, A. M., Morris, J. C., Mihailidis, A., & Roe, C. M. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00852-1 · Cited by 91
Inferring mobility measures from GPS traces with missing data
Barnett, I., & Onnela, J.-P. (2020) · Biostatistics · doi:10.1093/biostatistics/kxy059 · Cited by 84 · cited 1×
“Thus, thorough data cleaning is necessary to ensure that enough data points are captured to accurately represent activity for a given time period, as has been described previously [71,72].”
BackgroundRamos, E. M., Dokuru, D. R., Van Berlo, V., Wojta, K., Wang, Q., Huang, A. Y., Deverasetty, S., Qin, Y., van Blitterswijk, M., Jackson, J., et al. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12011 · Cited by 80 · cited 1×
“…variant in an autosomal dominant FTLD gene (ie, a pathogenic expansion in the chromosome 9 open reading frame 72 [C9orf72] gene or a known pathogenic or likely pathogenic variant in the progranulin (GRN) or microtubule-associated protein tau [MAPT] genes; conducted as described previously [36]).”
BackgroundSelf-citationPaolillo, E. W., Lee, S. Y., VandeBunte, A. M., Djukic, N. A., Fonseca, C. S., Kramer, J. H., & Casaletto, K. B. (2022) · Frontiers in Digital Health · doi:10.3389/fdgth.2022.884208 · Cited by 77 · cited 1×
“This has also been reported in other devices as well, including wearables [68-70].”
BackgroundSelf-citationEarly vs late age at onset frontotemporal dementia and frontotemporal lobar degeneration
Seo, S. W., Thibodeau, M., Perry, D. C., Hua, A. Y., Sidhu, M., Sible, I. J., Vargas, J. N. S., Gaus, S. E., Rabinovici, G. D., Rankin, K. D., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005163 · Cited by 72 · cited 1×
“FTLD encompasses a group of neuropathologically distinct diseases that result in an overlapping set of dementia syndromes with heterogeneous symptoms, including those defined by primary behavior, language, or sensorimotor changes [3,4].”
BackgroundSelf-citationLam, K., Meijer, K. A., Loonstra, F. C., Coerver, E. M. E., Twose, J., Redeman, E. G. M., Moraal, B., Barkhof, F., de Groot, V., Uitdehaag, B. M. J., et al. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520968797 · Cited by 67
Sociodemographic characteristics of missing data in digital phenotyping
Kiang, M. V., Chen, J. T., Krieger, N., Buckee, C. O., Alexander, M. J., Baker, J. T., Buckner, R. L., Coombs, G., Rich-Edwards, J. W., Carlson, K. W., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-94516-7 · Cited by 66 · cited 1×
“…a number of factors that influence the collection and transfer of smartphone data to secure cloud-based servers, including smartphone hardware, data permissions, app engagement, wireless service, capacity of local data storage, data transmission limits, and even sociodemographic factors [65-67].”
BackgroundDi, J., Demanuele, C., Kettermann, A. E., Karahanoğlu, F. I., Cappelleri, J. C., Potter, A., Bury, D. P., Cedarbaum, J. M., & Byrom, B. (2021) · Contemporary Clinical Trials · doi:10.1016/j.cct.2021.106661 · Cited by 63
Wearable device and smartphone data quantify ALS progression and may provide novel outcome measures
Johnson, S. A., Karas, M., Burke, K. M., Strączkiewicz, M., Scheier, Z. A., Clark, A., Iwasaki, S., Lahav, A., Iyer, A., Onnela, J.-P. “., et al. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00778-y · Cited by 60
Self-citationCurrey, D., & Torous, J. B. (2023) · BMJ Mental Health · doi:10.1136/bmjment-2023-300718 · Cited by 52
Papadopoulos, A., Iakovakis, D., Klingelhoefer, L., Bostantjopoulou, S., Chaudhuri, K. R., Kyritsis, K., Hadjidimitriou, S., Charisis, V., Hadjileontiadis, L. J., & Delopoulos, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-78418-8 · Cited by 51
Staffaroni, A. M., Asken, B. M., Casaletto, K. B., Fonseca, C., You, M., Rosen, H. J., Boxer, A. L., Elahi, F. M., Kornak, J., Mungas, D., et al. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12214 · Cited by 49 · cited 1×
“…published Uniform Data Set (Version 3) Executive Function composite score was used as our measure of executive functioning, comprising Trail Making Test A and B, phonemic fluency (generating words beginning with F and L), number span backwards, and category fluency (animals and vegetables) [41,42].”
MethodSelf-citationOlney, N. T., Ong, E., Goh, S. M., Bajorek, L., Dever, R., Staffaroni, A. M., Cobigo, Y., Bock, M., Chiang, K., Ljubenkov, P., et al. (2020) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.08.196 · Cited by 46 · cited 1×
“Details of image acquisition, processing, and harmonization have been published elsewhere [48].”
Self-citationBlack, C. M., Fillit, H. M., Xie, L., Hu, X., Kariburyo, M. F., Ambegaonkar, B. M., Başer, O., Yüce, H., & Khandker, R. K. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170518 · Cited by 45 · cited 1×
“The timely detection of neurodegenerative diseases such as FTLD is a core public health strategy to reduce the individual, caregiver, and socioeconomic burden of dementia [5-7].”
BackgroundLangener, A. M., Stulp, G., Jacobson, N. C., Costanzo, A., Jagesar, R. R., Kas, M. J., & Bringmann, L. F. (2024) · Advances in Methods and Practices in Psychological Science · doi:10.1177/25152459231202677 · Cited by 45 · cited 1×
“Thus, thorough data cleaning is necessary to ensure that enough data points are captured to accurately represent activity for a given time period, as has been described previously [71,72].”
BackgroundDi, X. S., Shi, R., DiGuiseppi, C. G., Eby, D. W., Hill, L. L., Mielenz, T. J., Molnar, L. J., Strogatz, D. S., Andrews, H., Goldberg, T. E., et al. (2021) · Geriatrics · doi:10.3390/geriatrics6020045 · Cited by 41 · cited 1×
“Naturalistic behavioral data collected via in-home remote sensors have shown sensitivity to clinical severity in Alzheimer disease [17-25]; for example, older adults with mild cognitive impairment exhibit significant declines in the number of days with computer use and daily time spent on the…”
BackgroundAmount and type of everyday technology use over time in older adults with cognitive impairment
Hedman, A., Nygård, L., Almkvist, O., & Kottorp, A. (2015) · Scandinavian Journal of Occupational Therapy · doi:10.3109/11038128.2014.982172 · Cited by 38 · cited 1×
“These findings are consistent with previous studies showing that older adults with cognitive impairment have greater declines in everyday technology use compared to cognitively unimpaired older adults [18,51,52].”
ResultStringer, G., Couth, S., BROWN, L. J. E., Montaldi, D., Gledson, A., Mellor, J., Sutcliffe, A., Sawyer, P., Keane, J. A., Bull, C., et al. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4863 · Cited by 38
Associations between smartphone keystroke dynamics and cognition in MS
Chen, M. H., Leow, A., Ross, M. K., DeLuca, J., Chiaravalloti, N. D., Costa, S. L., Genova, H. M., Weber, E., Hussain, F., & Demos, A. P. (2022) · Digital Health · doi:10.1177/20552076221143234 · Cited by 35 · cited 1×
“…markers of neurobehavioral function in older adults; for example, passively collected data from smartphone accelerometers, GPS location, and touchscreen typing have been associated with symptom and disease severity in Parkinson disease, multiple sclerosis, and amyotrophic lateral sclerosis [55-64].”
BackgroundA framework for handling missing accelerometer outcome data in trials
Tackney, M. S., Cook, D. G., Stahl, D. R., Ismail, K., Williamson, E., & Carpenter, J. R. (2021) · Trials · doi:10.1186/s13063-021-05284-8 · Cited by 34 · cited 1×
“This has also been reported in other devices as well, including wearables [68-70].”
BackgroundDetermining sample size and length of follow-up for smartphone-based digital phenotyping studies
Barnett, I., Torous, J. B., Reeder, H. T., Baker, J. T., & Onnela, J.-P. “. (2020) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa201 · Cited by 31 · cited 1×
“…a number of factors that influence the collection and transfer of smartphone data to secure cloud-based servers, including smartphone hardware, data permissions, app engagement, wireless service, capacity of local data storage, data transmission limits, and even sociodemographic factors [65-67].”
BackgroundGower, A. D., & Moreno, M. A. (2018) · JMIR mHealth and uHealth · doi:10.2196/11012 · Cited by 30
Hedman, A., Nygård, L., Almkvist, O., & Kottorp, A. (2013) · Aging & Mental Health · doi:10.1080/13607863.2013.777396 · Cited by 28 · cited 1×
“These findings are consistent with previous studies showing that older adults with cognitive impairment have greater declines in everyday technology use compared to cognitively unimpaired older adults [18,51,52].”
ResultLam, K., Twose, J., Lissenberg-Witte, B. I., Licitra, G., Meijer, K. A., Uitdehaag, B. M. J., de Groot, V., & Killestein, J. (2022) · Journal of Medical Internet Research · doi:10.2196/37614 · Cited by 25
GreenHub: a large-scale collaborative dataset to battery consumption analysis of android devices
Pereira, R., Matalonga, H., Couto, M., Castor, F., Cabral, B., Carvalho, P., de Sousa, S. M., & Fernandes, J. P. (2021) · Empirical Software Engineering · doi:10.1007/s10664-020-09925-5 · Cited by 22 · cited 1×
“First, there are certainly caveats to our approach using battery percentage as a proxy for smartphone use, including factors that are difficult to quantify and adjust for, such as the impact of hardware, software, and service connection on battery life [73].”
BackgroundBernstein, J. P. K., Dorociak, K. E., Mattek, N., Leese, M. I., Beattie, Z., Kaye, J. A., & Hughes, A. M. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210049 · Cited by 22 · cited 1×
“Naturalistic behavioral data collected via in-home remote sensors have shown sensitivity to clinical severity in Alzheimer disease [17-25]; for example, older adults with mild cognitive impairment exhibit significant declines in the number of days with computer use and daily time spent on the…”
BackgroundTaylor, J. C., Heuer, H. W., Clark, A. L., Wise, A. B., Manoochehri, M., Forsberg, L., Mester, C., Rao, M., Brushaber, D., Kramer, J., et al. (2023) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12423 · Cited by 20 · cited 4×
“Clinically normal participants were statistically significantly younger ( P <.001) and more likely to be women ( P <.001) than those with prodromal or symptomatic FTLD, consistent with the larger parent study samples (ALLFTD Mobile App study [30]; ALLFTD [40,50]).”
BackgroundResultInfluentialSelf-citationKaras, M., Olsen, J. M., Strączkiewicz, M., Johnson, S. A., Burke, K. M., Iwasaki, S., Lahav, A., Scheier, Z. A., Clark, A., Iyer, A. S., et al. (2024) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.52050 · Cited by 20
Self-citationGledson, A., Asfiandy, D., Mellor, J., Dhafari, T. B., Stringer, G., Couth, S., Burns, A. S., Leroi, I., Zeng, X., Keane, J. A., et al. (2016) · IEEE International Conference on Healthcare Informatics (ICHI) · doi:10.1109/ichi.2016.22 · Cited by 14
Ikeda, Y., Maruta, M., Shimokihara, S., Nakamura, A., Han, G., & Tabira, T. (2021) · Gerontology · doi:10.1159/000518390 · Cited by 13 · cited 1×
“Other studies have shown that older adults with cognitive impairment report more difficulties using technology, representing a potential barrier to technology use [53,54].”
BackgroundToller, G., Cobigo, Y., Callahan, P. M., Appleby, B. S., Brushaber, D. E., Domoto‐Reilly, K., Forsberg, L. K., Ghoshal, N., Graff‐Radford, J., Graff‐Radford, N. R., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12898 · Cited by 11
Self-citationBaños, J. H. (2002) · Archives of Clinical Neuropsychology · doi:10.1016/s0887-6177(01)00125-1 · Cited by 11
Choosing the right time granularity for analysis of digital biomarker trajectories
Wakim, N. I., Braun, T., Kaye, J. A., Dodge, H. H., & ORCATECH, F. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12094 · Cited by 10 · cited 1×
“We used the first 30 days of participants’ smartphone data for this study with the goal of understanding whether approximately 1 month of smartphone monitoring could reflect baseline neurobehavioral status without capturing longitudinal disease-related decline [18,37].”
MethodSubsidies and substitution: An empirical study of the lifeline program
Ford, G. S. (2020) · Telecommunications Policy · doi:10.1016/j.telpol.2020.102075 · Cited by 8
Stringer, G., Couth, S., Heuvelman, H., Bull, C., Gledson, A., Keane, J. A., Rayson, P., Sutcliffe, A., Sawyer, P., Zeng, X., et al. (2022) · Aging & Mental Health · doi:10.1080/13607863.2022.2036946 · Cited by 8
National Institute of Neurological Disorders and Stroke (NINDS) (2019) · Definitions · doi:10.32388/608858 · Cited by 6
Hoeijmakers, A., Meijer, K. A., Alfonso, N., McConchie, H., Lam, K., & Killestein, J. (2021) · Neurology · doi:10.1212/wnl.96.15_supplement.4142 · Cited by 2
Tracking ALS Disease Progression Using Passively Collected Smartphone Sensor DataPreprint
Karas, M., Olsen, J. M., Strączkiewicz, M., Johnson, S. A., Burke, K. M., Iwasaki, S., Lahav, A., Scheier, Z. A., Clark, A., Iyer, A. S., et al. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4526533 · Cited by 1
Self-citationTaylor, J. C., Clark, A. L., Heuer, H. W., Wise, A. B., Manoochehri, M., Forsberg, L. K., Mester, C. T., Rao, M., Brushaber, D. E., Kramer, J. H., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.068000 · Cited by 1
Self-citation
Research works printed but not linked: 2
- Workshop on applying digital technology for early diagnosis and monitoring of Alzheimer’s disease and related dementiasNational Institutes of Health National Institute on Aging2024-04-03https://www.nia.nih.gov/research/dn/workshops/workshop-applying-digital-technology-early-diagnosis-and-monitoring
- Li, H, 2024, arXiv. Preprint posted online January 12, 2018
Cited by
A meta-analysis of technology use and cognitive aging
Benge, J. F., & Scullin, M. K. (2025) · Nature Human Behaviour · doi:10.1038/s41562-025-02159-9 · Cited by 114
Shaik, M. A., Anik, F. I., Hasan, M. M., Chakravarty, S., Ramos, M. D., Rahman, M. A., Ahamed, S. I., & Sakib, N. (2025) · JMIR Aging · doi:10.2196/69175 · Cited by 37
“Conditions such as vascular dementia [22,23], Lewy body dementia [24], and frontotemporal dementia [25] share overlapping symptoms [26,27], including cognitive decline, behavior changes, and mobility issues, which can similarly benefit from remote monitoring interventions.”
Hackett, K., Xu, S., McKniff, M., Paglia, L., Barnett, I., & Giovannetti, T. (2024) · JMIR Human Factors · doi:10.2196/59974 · Cited by 33
Developing digital health technologies for frontotemporal degeneration
Nevler, N., Niehoff, D., Gleixner, A. M., Dodge, S., Vogel, A. P., Hill, D. L., Ducharme, S., Staffaroni, A. M., Yunusova, Y., Au, R., et al. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.70082 · Cited by 7
Self-citationReview of Artificial Intelligence for Clinical Use in Alzheimer's Disease and Related Dementias
Breithaupt, A. G., Tang, A., Paolillo, E. W., Bibars, M., Johnson, E. C. B., Saloner, R., Possin, K. L., Windon, C. C., Hill-Jarrett, T. G., Giorgio, J., et al. (2026) · Seminars in Neurology · doi:10.1055/a-2744-9871 · Cited by 6
Self-citation
Metadata
- Authors
- Paolillo, E. W., Casaletto, K. B., Clark, A. L., Taylor, J. C., Heuer, H. W., Wise, A. B., Dhanam, S., Sanderson-Cimino, M., Saloner, R., Kramer, J. H., Kornak, J., Kremers, W., Forsberg, L., Appleby, B., Bayram, E., Bozoki, A., Brushaber, D., Darby, R. R., Day, G. S., Dickerson, B. C., Domoto-Reilly, K., Elahi, F., Fields, J. A., Ghoshal, N., Graff-Radford, N., G H Hall, M., Honig, L. S., Huey, E. D., Lapid, M. I., Litvan, I., Mackenzie, I. R., Masdeu, J. C., Mendez, M. F., Mester, C., Miyagawa, T., Naasan, G., Pascual, B., Pressman, P., Ramos, E. M., Rankin, K. P., Rexach, J., Rojas, J. C., VandeVrede, L., Wong, B., Wszolek, Z. K., Boeve, B. F., Rosen, H. J., Boxer, A. L., Staffaroni, A. M., & ALLFTD Consortium
- Affiliations
- University of California, San Francisco (US)
- Mayo Clinic (US)
- Case Western Reserve University (US)
- University of California San Diego (US)
- University of North Carolina at Chapel Hill (US)
- Vanderbilt University (US)
- Mayo Clinic in Florida (US)
- Harvard University (US)
- James J. Peters VA Medical Center (US)
- Washington University in St. Louis (US)
- Columbia University (US)
- Brown University (US)
- University of British Columbia (CA)
- Weill Cornell Medicine (US)
- University of California, Los Angeles (US)
- Icahn School of Medicine at Mount Sinai (US)
- University of Colorado Anschutz (US)
- Corresponding author
- Paolillo, Emily W
- ORCID
- Paolillo, Emily W
- Casaletto, Kaitlin B
- Clark, Annie L
- Taylor, Jack C
- Heuer, Hilary W
- Wise, Amy B
- Dhanam, Sreya
- Sanderson-Cimino, Mark
- Saloner, Rowan
- Kramer, Joel H
- Kornak, John
- Kremers, Walter
- Forsberg, Leah
- Appleby, Brian
- Bayram, Ece
- Bozoki, Andrea
- Brushaber, Danielle
- Darby, R Ryan
- Day, Gregory S
- Dickerson, Bradford C
- Domoto-Reilly, Kimiko
- Elahi, Fanny
- Fields, Julie A
- Ghoshal, Nupur
- Graff-Radford, Neill
- G H Hall, Matthew
- Honig, Lawrence S
- Huey, Edward D
- Lapid, Maria I
- Litvan, Irene
- Mackenzie, Ian R
- Masdeu, Joseph C
- Mendez, Mario F
- Mester, Carly
- Miyagawa, Toji
- Naasan, Georges
- Pascual, Belen
- Pressman, Peter
- Ramos, Eliana Marisa
- Rankin, Katherine P
- Rexach, Jessica
- Rojas, Julio C
- VandeVrede, Lawren
- Wong, Bonnie
- Wszolek, Zbigniew K
- Boeve, Bradley F
- Rosen, Howard J
- Boxer, Adam L
- Staffaroni, Adam M
- Venue
- JMIR Aging
- Publisher
- JMIR Publications Inc.
- Published
- 2024-06-26
- Volume
- 7
- Pages
- e52831
- ISSN
- 2561-7605 (ISSN-L)
- PMC
- PMC11237775
- OpenAlex
- W4400039427
- Cited by
- 16
- References
- 75
- Citations by year
- 2026: 9 · 2025: 6 · 2024: 1
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- JMIR Aging (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion, cc-by)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UNC Libraries
- Funders
- U.S. Department of Veterans Affairs (IK2CX002180)
- Alzheimer's Association (AARF-23-1145318, AARF-22, AARF-22-974065)
- Association for Frontotemporal Degeneration
- Eli Lilly and Company
- Pfizer
- Biogen
- University of Southern California
- University of Pennsylvania
- Emory University
- Northwestern University
- Cleveland Clinic
- University of Washington
- Johns Hopkins University
- CurePSP
- Demensförbundet
- Horizon Pharmaceuticals
- Rainwater Charitable Foundation
- University of Toronto
- Eisai
- Universiteit Antwerpen
- National Institutes of Health (1r21ns114764-01a1, AG016976, AG019724, AG021886, AG063911, AG045390, AG058233, NS050915, AG032306, NS092089)
- Centers for Disease Control and Prevention
- University of California, San Diego
- University of California, San Francisco (AG019724)
- National Institute on Aging (R01AG058233, K23AG059888, U01AG057195, U01AG016976, K23AG061253, U01AG045390, R01AG032306, K23AG064029, RF1AG077557, RF1AG032289, U19AG032438, K24AG045333, R01AG038791, U19AG063911, R01AG077557, P01AG019724, P30AG062422, K23AG073514, P30AG066514, P30AG062677, P30AG066509, R01AG032289, U24AG021886)
- National Institute of Neurological Disorders and Stroke (R21 NS114764, K08NS105916, RF1NS050915, R56NS050915, U54NS092089, U01NS120901, R25NS098999, R01NS050915, U01NS100610)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Social Sciences › Psychology › Clinical Psychology › Historical and Modern Theater Studies
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- frontotemporal lobar degeneration, frontotemporal dementia, smartphone use, remote monitoring, disease severity, familial frontotemporal lobar degeneration, neurobehavioral symptoms, neuropsychiatric symptoms, neuropsychological assessment, mobile health, non-intrusive monitoring
- MeSH terms
- Smartphone, Proof of Concept Study, Adult, Aged, Female, Humans, Longitudinal Studies, Male, Middle Aged, Neuropsychological Tests, Severity of Illness Index, Frontotemporal Dementia, Mobile Applications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.